Inmune Bio INMB
NASDAQ INMB
$1.10 +0.00 (+0.00%)
At close: Nov 11, 2026 · 4:00 PM EST

Inmune Bio (INMB) Depreciation and Depletion (2025 - 2026)

Updated

Inmune Bio's Depreciation and Depletion came in at $100,000 for Q2 2026, up 92.3% from the prior quarter.

Analysis

Inmune Bio (INMB) Depreciation and Depletion (2025 - 2026) Analysis & Trends

For FY2025, Inmune Bio's Depreciation and Depletion was $84,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Depletion (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 192.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 726.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 132.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Inmune Bio 30.71 Mn -50.14 Mn - 100,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 100,000.00
Jun 30, 2026 100,000.00
Mar 31, 2026 52,000.00
Dec 31, 2025 56,000.00
API Access

Inmune Bio Depreciation and Depletion API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=INMB&period=max&api_key=YOUR_API_KEY